Gastroretentive Dosage Forms for Prolonging Gastric Residence Time

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.2, 2007-01, pp. : 157-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Floating Drug Delivery Systems for Prolonging Gastric Residence Time: A Review

Current Drug Delivery, Vol. 8, Iss. 5, 2011-09 ,pp. : 494-510

Bentham Science Publishers

Access to resources Recommend Favorite

Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems

By Pawar Vivek K. Kansal Shaswat Garg Garima Awasthi Rajendra Singodia Deepak Kulkarni Giriraj T.

Drug Delivery, Vol. 18, Iss. 2, 2011-02 ,pp. : 97-110

Informa Healthcare

Access to resources Recommend Favorite

Novel Gastroretentive Dosage Forms: Evaluation of Gastroretentivity and Its Effect on Levodopa Absorption in Humans

By Klausner Eytan A. Lavy Eran Barta Miklos Cserepes Eva Friedman Michael Hoffman Amnon

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1466-1473

Springer Publishing Company

Access to resources Recommend Favorite

Pharmaceutical Formulations to Increase Gastric Residence Time: Concepts and Strategies

Drug Delivery Letters, Vol. 7, Iss. 3, 2017-11 ,pp. : 190-200

Bentham Science Publishers

Access to resources Recommend Favorite

Bioavailability of valsartan oral dosage forms

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 132-138

John Wiley & Sons Inc

Access to resources Recommend Favorite